Upload
mahsa
View
36
Download
0
Embed Size (px)
DESCRIPTION
Circulatory failure in Intensive Care. Dr…. Circulatory System. Ensures adequate blood flow to supply metabolic demands of the tissues Regulation via cardiac pump and peripheral vascular system Pump control varies the cardiac output - PowerPoint PPT Presentation
Citation preview
Circulatory failure in Intensive Care
Dr….
Circulatory System
• Ensures adequate blood flow to supply metabolic demands of the tissues
• Regulation via cardiac pump and peripheral vascular system
• Pump control varies the cardiac output
• PVS control regulates intravascular volume, vascular resistance, perfusion pressure and appropriately distributes flows to vascular beds
Circulatory failure = shock
‘Tissue perfusion is inadequate for the metabolic needs of the
patient’
Inadequate O2 delivery
• Inadequate O2 delivery represents an imbalanceimbalance of delivery relative to need
• This imbalance between supply and demand leads to the development of tissue hypoxiatissue hypoxia
• Changes in systemic perfusion are always present in shock
Classification of Shock
• Cardiogenic– Infarction/ischaemic VSD/myocarditis– Valvular abnormalities/PE/Tamponade
• Hypovolaemic– Haemorrhage– Excessive fluid loss from GI/Renal tracts/Burns
• Septic• Neurogenic• Anaphylactic
Oxygen delivery (DO2)
• Amount of O2 delivered to peripheral tissues
• Dependent on arterial O2 content and cardiac output
• In health this is about 1005ml/min
• DO2 is reduced in cardiogenic and hypovolaemic shock (impaired contractility and reduced myocardial preload respectively)
Oxygen Transport
DO2
Oxygen transport
SaO2
Arterial oxygen
saturation
= 1.34
Oxygen content of 1g fully saturated
haemoglobin
x
Arterial Oxygen Content
[Hba]
Arterial haemoglobin concentration
x COx
Cardiac output
Oxygen uptake (VO2)
• Amount of O2 taken up by the tissues
• It is the difference between DO2 and O2 returned to lung in mixed venous blood
• In health this is about 760 ml/min
• An oxygen debt occurs when uptake exceeds delivery (as occurs in shock) and severity can be monitored by rising blood lactate (anaerobic metabolism)
Septic Shock
• Soluble cell bound receptors recognize microbial components or their toxins and stimulate release of pro-inflammatory and anti-inflammatory cytokines, complement, coagulation activation and platelet aggregation.
• This results in vasodilatation and reduced intra-vascular volume (due increased vascular permeability)
• Despite reduced contractility cardiac output is often increased in septic shock due to reduced afterload
Septic Shock
• Initially DO2 is elevated in septic shock primarily due to increased CO
• However, VO2 is also raised due to increased metabolic activity of the tissues
• When VO2 exceeds DO2 a lactic acidosis results
• Untreated this leads to multi-organ failure
Clinical presentation of septic shock
• Hyperdynamic (unless significant hypovolaemia)
• Proven source of infection
• Hypotension
• Signs of systemic inflammation (tachycardia, tachypnoea, hypo/perthermia, leuko-cytosis/paenia)
• Confused, tachycardic, tachypnoeic, oliguric
• Bounding pulses and warm peripheries
Hypovolaemic and cardiogenic shock • Low cardiac output
• BP can initially be normal due to compensatory sympathetic and neuro-hormonal mechanisms
• Patients will be confused, pale, tachycardic, tachypnoeic, poor perfusion and oliguric
• CVP low in HV shock
• CVP high in CG shock with associated pulmonary oedema
Investigations
• Tailor to history and clinical findings.
• FBC, Clotting, Electrolytes, Cr, Ur, Clotting, CRP, ABGs, lactate, troponin and blood cultures.
• ECG, CXR.
• ECHO (ventricular function, wall motion abN, valvular dysfunction, Tamponade, PE (spiral CT and pulmonary angiography)).
• DPL, abdo USS, CT (concealed haemorrhage).
Management
• General measures for all patients with shock.
• Specific appropraiate to aetiology.
Target areas for treatment
• Reduction of metabolic demands
• Adequate O2 provision
• Normalisation of filling
• Manipulation of vasculature with Vasoactive agents
• Normalization of SV
• Manipulation of pump with Inotropes
CAN WE REDUCE DEMAND?
DO WE EVER DO IT?
Yes!
Yes!
Management - Respiratory
• High flow O2 (improve SaO2 and tissue DO2).
• Ventilatory support or mechanical ventilation (reduces VO2 by resp muscles).
• Early intubation facilitates invasive haemodynamic monitoring.
• VO2resp = Oxygen consumed by work of breathing
• VO2tot = Total oxygen consumption
0
5
10
15
20
25
30
Normals CTxsurgery
COPD PulmonaryoedemaV
O2r
esp
as
per
cen
tag
e o
f V
O2t
ot
Intensive Care Med. 1995 Mar;21(3):211-7.
So ventilatory support reduces oxygen demands
In COPD, PS by mask can reduce this to almost
zero
Ventilatory support
• CPAP:
• Recruits alveoli
• Improves V/Q
• Improves oxygenation
• Reduces work of breathing
• BIPAP???
Adequate sedation reduces
oxygen demand
Crit Care Med. 2003 Mar;31(3):830-3.
• 32 post- oesophagectomy/ head and neck malignancies
• All buprenorphine -> Midazolam – light
– mod
– heavy sedation
0
20
40
60
80
100
120
140
160
Light Moderate HeavyOX
YG
EN
CO
NS
UM
PT
ION
ml/m
in/m
2
Paralysis reduces muscle
oxygen consumption
Chest. 1996 Apr;109(4):1038-42.
• 8 patients
• Mean age 63 years
• Benzodiazipine + morphine
• Then doxacurium paralysis
• Mandatory ventilation
• O2 consumption measured
0
20
40
60
80
100
120
140
160
180
200
-paralysis +paralysisOX
YG
EN
CO
NS
UM
PT
ION
ml/m
in/m
2
25% reduction
Cooling reduces
oxygen consumption
Am J Resp Crit Care Med 1995 Jan;151(1):10-4
0
50
100
150
200
250
300
350
400
Hot Normal
OX
YG
EN
CO
NS
UM
PT
ION
ml/m
in
•12 febrile, critically ill, mechanically ventilated patients
•T down from 39.4 +/- 0.8 -> 37.0 +/- 0.50C
HOW DO WE IMPROVE DELIVERY?HOW DO WE IMPROVE DELIVERY?
3 ways
• Optimize O2 supplementation to patient
• Optimization of Filling
• Optimization of SV– Volume
– Vasoactive drugs
– Inotropes
MANAGEMENT OF SHOCK
A: RECOGNISE WHAT TYPE OF SHOCK YOU
ARE DEALING WITH
B: CORRECT THE FILLING STATUS Empty as a primary cause eg haemorrhage
Empty in sepsis due to increased capacitance
C: ONLY THENC: ONLY THEN USE VASO-ACTIVE AGENTS: BETA-1 AGONISTS TO DRIVE THE HEART
ALPHA-1 AGONISTS OR COOLING TO VASOCONSTRICT
GTN OR WARMTH TO VASODILATE
Targets?
HISTORYHISTORY• What BP is ‘normal’?
CLINICALCLINICAL• Cerebration• Peripheral perfusion
MONITORINGMONITORING• Urine (0.5ml/kg/hr minimum)• ABG (degree of acidosis, trend)
AIM FOR INDICES OF ADEQUATE ORGAN PERFUSION, NOT BPAIM FOR INDICES OF ADEQUATE ORGAN PERFUSION, NOT BP
What is the type of shock?
• Cardiogenic shock – pump failure – ischaemic / trauma / drugs
• Hypovolaemic shock– haemorrhage
• Low resistance circulatory / distributive shock
– drugs / sepsis
FALL IN FLOW
Volume loss
Bleed
Diarrhoea
Burns
Fall in filling
PE
Tension PTx
Tamponade
Fall in cardiac contractility
Basic Physiology
= FLOW
BLOOD PRESSURE = CARDIAC OUTPUT X RESISTANCE
PRESSURE X RESISTANCE
Aortic arch and carotid sinus baroreceptors detect a drop in pressure
Efferent activity to Medulla falls
Sympathetic efferents
THE RESPONSE IS THE SAME…
INCREASED SYMPATHETIC ACTIVITY CAUSES
• VENOCONSTRICTION– INCREASES FILLING PRESSURE AND SUSTAINS
STROKE VOLUME
• POSITIVE INOTROPIC EFFECT– SUSTAINS STROKE VOLUME
• TACHYCARDIA– INCREASES CARDIAC OUTPUT
• VASOCONSTRICTION– INCREASES RESISTANCE
PRESSURE = FLOW (UP) X RESISTANCE (UP)
Management - Fluids
• Optimize preload.
• Restore circulating volume.
• Large vols in HV/septic shock (latter - aim SvO2 >70% / Hb >10g/dl reduce hosp mort by 16%).
• Judicious vols in CG shock (PAoP/CI).
200ml COLLOID CHALLENGEUnder filled
<3mmHg
Well filled
3mmHg
Over filled
>3mmHg
Stroke volume PAWP
Blood volume Blood volume
20mmHg
Filling
LVF: Physiology
Pulmonary Capillaries
Pulmonary Veins
LA
LV
MVAt end-diastole, MV is open, flow has ‘ceased’
SO LVEDP = LAP = PVP = PCP
= HYDROSTATIC PCP
Management - Fluids
• CVP surrogate for preload
• Oesophageal doppler better measure of filling
• Fluid should be used to replace that lost
• Aim Hb 7-9 g/dl
• Higher mortality if aim Hb 10-12 g/dl.
Management - Fluids• Crystalloid vs Colloid…..
• Colloids restore circ vol more efficiently, but no worse outcome with crystalloid only
• Systematic review colloid use – 4% increase in mortality (esp HAS)
• SAFE study
• Hypertonic solutions may be useful in pts with cerebral oedema requiring fluid resuscitation and may reduce fluid and Blood Tx requirements.
Management - Inotropes
• HV shock – rarely needed – fluids alone restore CO and BP
• CG shock – fluids not helpful, inotropes needed
• Septic shock – fluids needed as well as inotropes
• Both require vasoactive drugs to improve tissue perfusion and reverse tissue hypoxia.
Inotropic support
Filling pressure (mmHg)
SV (ml)
5
60
RV
LV
10
Management - Inotropes
• CG shock – (low CO/BP and elevated SVR).
• Inodilator (Dobutamine/Milrinone) if BP not too low.
• Inodilator plus inoconstrictor (Adrenaline/Dopamine) or vasopressor (NorAdr) if BP compromised.
• Adr S/E – hyperglycaemia/hypokalaemia/hyperlactataemia (interpret Lactate levels with caution).
Management - Inotropes
• Septic shock – (high CO low BP from peripheral vasodilatation).
• Firstly optimize preload.• Then use vasopressor (NorAdr)• If CO is reduced consider adding
Dobutamine.• Dopamine (inoconstrictor) could be used but
associated with adverse effects on pituitary (reduced prolactin/GH/TRH), T-cell function, gut mucosa perfusion and renal medullary VO2.
Doses
Dobutamine (5-20µg/kg/min)
–adjust by 2.5µg/kg/min increments
Adrenaline (start at 0.05µg/kg/min)
–adjust by 0.02µg/kg/min increment
–GTN to lower resistance
Hypovolaemic shock
• In case of haemorrhagic shock – stop the bleeding (surgery/radiology/endoscopy)
• Fluid resuscitation
• Correct hypovolaemia/hypoxia/anaemia and increase DO2 prior to surgery to reduce peri-operative mortality
Heart Rate
Blood pressure
CVP
50%PERCENTAGE BLOOD LOSS
THE SIGNS OF BLEEDING MAY THE SIGNS OF BLEEDING MAY
THEREFORE BE MASKED:THEREFORE BE MASKED:• CVP MAINTAINED
• BLOOD PRESSURE MAINTAINED (NB Postural drop?)
……SO SEEK SIGNS OF SO SEEK SIGNS OF • SYMPATHETIC ACTIVATION SYMPATHETIC ACTIVATION
• IMPAIRED PERFUSION IMPAIRED PERFUSION – Clinical
– Acidaemia
Septic shock
• Drain infected fluid collections.
• Antibiotics – broad spectrum – narrowed cover when culture results available.
• Steroids – 30-120mg/kg methyl pred within 24 hrs onset improve haemodynamic stability but not survival.
• 100mg hydrocortisone 8 hrly 24-72 hrs after onset in pts requiring vasopressors with a sub-N rise in Se cortisol in response to ACTH (SST) improves haemodynamics and outcome.
Septic shock
• High volume haemofiltration.
• Used to manage severe metabolic acidosis and renal failure.
• Cytokines may be removed in the ultrafiltrate and by adsorption onto the filter and improve haemodynamic stability.
Cardiogenic shock
• High mortality when complicating acute MI.
• Not reduced significantly by thrombolytic therapy.
• Angioplasty or CABG should be performed without delay.
• IABP – useful bridge to surgery in papillary muscle rupture and ischaemic VSD.
Pathophysiology of cardiac failure
• Pump failure (ischaemia/drugs/sepsis)
• Ventricular failure
• Reduced SV
– Reduced CO
– Increased baroreceptor activity
• Venoconstriction
• Increased ventricular filling pressure and myocardial fibre length – increasing contractility – restoring SV towards normal
LV and RV curves are splayed
EDP (mmHg)
SV (ml)
5
60
RV
LV
10
LVF: Starling curve
Pathophysiology of cardiac failure
• Eventually the myocardial fibres are unable to generate further increase in contractility – resulting in reduction in CO.
• Venous pressure becomes so high that pulmonary and peripheral oedema ensues.
LVF: Physiology
SURFACE TENSION RADIUS 4
Alveolus
Starling forces
• The balance of hydrostatic and osmotic (oncotic) pressures between capillary plasma and interstitial fluid causes fluid to be filtered out of the capillary at the alveolar end and reabsorbed at the venous end
LVF: Physiology
ONCOTIC PRESSURE
Hydrostatic Pressure>
Oncotic pressure
HYDROSTATICPRESSURE<
SURFACE TENSION RADIUS 4
LV FAILURE DEPRESSES THE GRAPH
Filling pressure (mmHg)
SV (ml)
5
60
RV
LV
10
LVF: Physiology 6
CONSEQUENTLY
In acute depression of LV function:• LVEDP rises
• LAP rises
• PVP rises
• PCP rises
Cardiac Failure – vasoactive drugs
• Optimize / reduce ventricular filling pressure – with diuretics, venodilators and warmth.
• Reduce cardiac work and increase SV with vasodilators (eg. GTN or warmth)
• Drive the heart with Beta 1 agonists to increase CO (by increasing HR)
– CO = HR x SV
• Enhance contractility to increase SV – expense of increased myocardial work and O2 consumption.
– Aim SV of 1ml/kg
• Cardiac work is determined by CO (vol of blood pumped) and vascular resistance (resistance against which it is pumped).
Warning….
• In cardiac failure CO is reduced already.
• Vascular resistance falls further with vasodilators – which can enhance cardiac performance.
• Vasodilatation further reduces BP and thus can impair organ perfusion .
Management - Diuretics
• Use of low-dose “renal-dose” Dopamine to prevent renal failure in pts with shock does not reduce the number of pts requiring RRT.
• Natriuesis can be achieved with Frusemide (bolus 10-80mg or infusion 3-10mg/hr).
• Ensure adequate fluid resuscitation prior to use.
Frusemide
SV (ml)
Filling pressure (mmHg)
60
RV
LV
Diuresis
Dikshit et al. N Engl J Med 1973;228:1087-1090.
0 20 40 60 80
10
12
14
16
18
20
Time after 0.5-1.0 mg/kg frusemide (mins)
PAWP
n=22
PAWP (mmHg)
0.7
0.8
0.9
1.0
1.1
1.2
Venous capacitance
Venous Capacitance (ml/100ml)
Frusemide
Nitrates
• Venodilatation– Reduces LVEDP and PCP
• Vasodilatation– Increases SV
• CO falls….
Bussmann and Schupp Am J Cardiol 1978;41:931-936
0 2 4 6 8 10
20
22
24
26
28
30
32
34
Time after 1.6mg sublingual GTN (mins)
n=7
PAWP
PAWP (mmHg)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Cardiac Output
Cardiac Output (l/min)
Nitrates
NOW DILATED, YOUR PATIENT MAY BE UNDERFILLED.
With appropriate monitoring, you may correct cardiac output with fluid challenges....
No specific CVP to aim for….
Get the filling right
Outcome
• Dependent on: aetiology, severity of illness at presentation, response to therapy and co-morbidities.
• Generally mortality associated with HV shock is lower than that with CG and septic shock as long as source of haemorrhage can be controlled.
• Mortality (even in good centres) septic shock 30-50%, higher in CG shock.
Summary
• Consider Oxygen Provision in all
• Consider Oxygen Consumption in all
• Normalise filling
• Normalise stroke volume– Volume
– Dilate
– Inotropes
• Only THEN tinker with raising resistance